By Michael Erman and Julie Steenhuysen Aug 19 (Reuters) – Moderna and Merck said on Wednesday that a personalized mRNA cancer vaccine reduced the risk of recurrence and spread of melanoma in a
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Bonds steady after US Treasury comes to the rescue
By Rae Wee SINGAPORE, Aug 20 (Reuters) - Global bonds steadied on Thursday after the…
Item from behind in final strides to win International Stakes
VIDEO SHOWS: HIGHLIGHTS OF THE INTERNATIONAL STAKES WON BY ITEM WITH COLIN KEANE AS JOCKEY…
UPDATE 1-China leaves loan rates steady for 15th consecutive month in August
(Adds context and background) SHANGHAI, Aug 20 (Reuters) - China kept benchmark lending rates unchanged…
